UCB 62045: Pharmacology of a novel, dual-function anti-inflammatory agent with histamine type 1 receptor antagonist and 5-lipoxygenase inhibitor activity

Chest

Volumn 123, Issue 3 SUPPL., 2003, Pages

  Selig, William M ^a   Bayless, Lynn ^a   Libertine, Lyn ^a   Eckman, Joseph B ^a   Wypij, Donna M ^a   Wels, Bruce F ^a   Eckert, Maria ^a   Young, Michelle A ^a   Nicolas, Jean M ^a   Scannell, Ralph T ^a   Ellis, James L ^a  

^a UCB PHARMA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; ARACHIDONATE 5 LIPOXYGENASE; HISTAMINE; LEUKOTRIENE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; LORATADINE; METHYLCELLULOSE; MONTELUKAST; OVALBUMIN; UCB 62045; UNCLASSIFIED DRUG; ZAFIRLUKAST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRONCHOSPASM; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; GENETIC TRANSFECTION; MOLECULAR WEIGHT; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RHINITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARACHIDONATE 5-LIPOXYGENASE; BRONCHOCONSTRICTION; DISEASE MODELS, ANIMAL; GUINEA PIGS; HISTAMINE ANTAGONISTS;

EID: 0037336792     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)